RaySearch Laboratories AB (publ) (STO:RAY.B)
Sweden · Delayed Price · Currency is SEK 215.40
-1.20 (-0.55%)
At close: Jun 3, 2026
RaySearch Laboratories AB Market Cap
RaySearch Laboratories AB has a market cap or net worth of 7.38 billion as of June 3, 2026. Its market cap has decreased by -31.51% in one year.
Market Cap
7.38B
Enterprise Value
7.32B
Revenue
1.30B
Ranking
n/a
PE Ratio
32.96
Stock Price
215.40
Market Cap Chart
Since October 30, 2003, RaySearch Laboratories AB's market cap has increased from 189.23M to 7.38B, an increase of 3,802.33%. That is a compound annual growth rate of 17.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 7.43B | -5.00% |
| Dec 30, 2025 | 7.82B | 5.56% |
| Dec 30, 2024 | 7.41B | 139.20% |
| Dec 29, 2023 | 3.10B | 32.79% |
| Dec 30, 2022 | 2.33B | 20.35% |
| Dec 30, 2021 | 1.94B | -31.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 150.17B |
| Sectra AB | 54.41B |
| Getinge AB | 50.55B |
| Camurus AB | 33.04B |
| Ambea AB | 11.64B |
| Dynavox Group AB | 8.71B |
| Xvivo Perfusion AB | 8.44B |
| Synsam AB | 7.71B |